Inventor · disambiguated record
Seble H. Wagaw
Also filed as: WAGAW SEBLE · WAGAW SEBLE H
13 granted patents·6 pending applications·198 citations·filing 1998–2022
90Inventor score
Files withABBVIE INC11DEGOEY DAVID A3MASSACHUSETTS INST TECHNOLOGY2Abbott Labaoratories1MCDERMOTT TODD S1
Top patents by PatentIndex Score
19 records- 0194US8691938B2Anti-viral compoundsDEGOEY DAVID A·Filed 2010·Granted Apr 8, 2014·26 cites·2 claims
- 0293US6465693B2Metal-catalyzed arylations of hydrazines, hydrazones, and related substratesMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Oct 15, 2002·65 cites·20 claims
- 0393US6235936B1Metal-catalyzed arylations of hydrazines, hydrazones, and related substratesMASSACHUSETTS INST TECHNOLOGY·Filed 1998·Granted May 22, 2001·87 cites·22 claims
- 0489US8937150B2Anti-viral compoundsDEGOEY DAVID A·Filed 2011·Granted Jan 20, 2015·11 cites·18 claims
- 0582US9006387B2Anti-viral compoundsABBVIE INC·Filed 2014·Granted Apr 14, 2015·4 cites·9 claims
- 0676US9469673B2Crystaline forms of HCV inhibitorABBVIE INC·Filed 2013·Granted Oct 18, 2016·4 cites·12 claims
- 0771US8921514B2Anti-viral compoundsDEGOEY DAVID A·Filed 2010·Granted Dec 30, 2014·1 cites·7 claims
- 0864US9586978B2Anti-viral compoundsABBVIE INC·Filed 2014·Granted Mar 7, 2017·0 cites·21 claims
- 0962US2023285378A1Anti-Viral CompoundsABBVIE INC·Filed 2022·Application pending·0 cites
- 1062US2019015402A1Anti-Viral CompoundsABBVIE INC·Filed 2018·Application pending·0 cites
- 1159US10039754B2Anti-viral compoundsABBVIE INC·Filed 2017·Granted Aug 7, 2018·0 cites·17 claims
- 1259US10028937B2Anti-viral compoundsABBVIE INC·Filed 2017·Granted Jul 24, 2018·0 cites·4 claims
- 1357US9309279B2Macrocyclic hepatitis C serine protease inhibitorsABBVIE INC·Filed 2014·Granted Apr 12, 2016·0 cites·17 claims
- 1454US2011092415A1Anti-Viral CompoundsAbbott Labaoratories·Filed 2010·Application pending·0 cites
- 1553US2015218194A1Anti-Viral CompoundsABBVIE INC·Filed 2015·Application pending·0 cites
- 1651US9260411B2Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrileMCDERMOTT TODD S·Filed 2007·Granted Feb 16, 2016·0 cites·8 claims
- 1750US8193346B2Process for making macrocyclic oximyl hepatitis C protease inhibitorsWAGAW SEBLE·Filed 2008·Granted Jun 5, 2012·0 cites·9 claims
- 1849US2015175612A1Crystal formsABBVIE INC·Filed 2014·Application pending·0 cites
- 1940US2016152600A1Synthesis of (2s,5r)-5-ethynyl-1-pyrrolidine-2-carbonitrileABBVIE INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seble H. Wagaw files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →